Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (41-50 of 200) with videos related to

Pageof 20
Sort By:
Thrombosis and Haemostasis|March 31, 2010
Platelet function testing and risk of bleeding complicationsJosé Luis Ferreiro, Dirk Sibbing, Dominick J Angiolillo
Thrombosis and Haemostasis|April 21, 2011
High platelet reactivity and clinical outcome - fact and fictionDirk Sibbing, Robert A Byrne, Isabell Bernlochner, et al.
Circulation|October 26, 2018
P2Y<sub>12</sub>-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary SyndromesLaurent Bonello, Dominick J Angiolillo, Daniel Aradi, et al.
Expert Review of Cardiovascular Therapy|September 1, 2011
The future of platelet function testing to guide therapy in clopidogrel low and enhanced respondersIsabell Bernlochner, Robert A Byrne, Adnan Kastrati, et al.
European Heart Journal|May 10, 2006
Patent foramen ovale with a riding vermicular thrombus causing paradoxical and massive pulmonary embolismDirk Sibbing, Matthias Overbeck, Roland Schmidt, et al.
Case Reports in Medicine|August 27, 2009
Very late stent thrombosis 42 months after implantation of sirolimus-eluting stent and discontinuation of antiplatelet therapyDirk Sibbing, Karl-Ludwig Laugwitz, Lorenz Bott-Flügel, et al.
Thrombosis and Haemostasis|October 25, 2013
A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patientsNiels Straub, Andreas Beivers, Ekaterina Lenk, et al.
International Journal of Cardiology|September 28, 2013
Cangrelor infusion is associated with an increased risk for bleeding: meta-analysis of randomized trialsVictor L Serebruany, Daniel Aradi, Moo Hyun Kim, et al.
International Journal of Cardiology|March 3, 2007
Intracardiac right ventricular metastatic tumor of malignant T-cell lymphomaDirk Sibbing, Petra Barthel, Kathrin Abbrederis, et al.
American Journal of Preventive Cardiology|January 12, 2023
Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implicationsMichael J Blaha, Magdy Abdelhamid, Francesca Santilli, et al.
Pageof 20

Showing results (41-50 of 200) with videos related to

Sort By:
Pageof 20
Thrombosis and Haemostasis|March 31, 2010
Platelet function testing and risk of bleeding complicationsJosé Luis Ferreiro, Dirk Sibbing, Dominick J Angiolillo
Thrombosis and Haemostasis|April 21, 2011
High platelet reactivity and clinical outcome - fact and fictionDirk Sibbing, Robert A Byrne, Isabell Bernlochner, et al.
Circulation|October 26, 2018
P2Y<sub>12</sub>-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary SyndromesLaurent Bonello, Dominick J Angiolillo, Daniel Aradi, et al.
Expert Review of Cardiovascular Therapy|September 1, 2011
The future of platelet function testing to guide therapy in clopidogrel low and enhanced respondersIsabell Bernlochner, Robert A Byrne, Adnan Kastrati, et al.
European Heart Journal|May 10, 2006
Patent foramen ovale with a riding vermicular thrombus causing paradoxical and massive pulmonary embolismDirk Sibbing, Matthias Overbeck, Roland Schmidt, et al.
Case Reports in Medicine|August 27, 2009
Very late stent thrombosis 42 months after implantation of sirolimus-eluting stent and discontinuation of antiplatelet therapyDirk Sibbing, Karl-Ludwig Laugwitz, Lorenz Bott-Flügel, et al.
Thrombosis and Haemostasis|October 25, 2013
A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patientsNiels Straub, Andreas Beivers, Ekaterina Lenk, et al.
International Journal of Cardiology|September 28, 2013
Cangrelor infusion is associated with an increased risk for bleeding: meta-analysis of randomized trialsVictor L Serebruany, Daniel Aradi, Moo Hyun Kim, et al.
International Journal of Cardiology|March 3, 2007
Intracardiac right ventricular metastatic tumor of malignant T-cell lymphomaDirk Sibbing, Petra Barthel, Kathrin Abbrederis, et al.
American Journal of Preventive Cardiology|January 12, 2023
Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implicationsMichael J Blaha, Magdy Abdelhamid, Francesca Santilli, et al.
Pageof 20